-
公开(公告)号:US09290496B2
公开(公告)日:2016-03-22
申请号:US14548749
申请日:2014-11-20
Applicant: PFIZER INC.
Inventor: Douglas Carl Behenna , Hengmiao Cheng , Sujin Cho-Schultz , Theodore Otto Johnson, Jr. , John Charles Kath , Asako Nagata , Sajiv Krishnan Nair , Simon Paul Planken
IPC: A61K31/519 , C07D473/18 , A61P35/00 , A61K31/5377 , C07D498/10 , A61K31/5386 , C07D487/04 , A61K31/52 , C07D473/16 , C07D519/00
CPC classification number: C07D473/16 , A61K31/519 , A61K31/52 , A61K31/5377 , A61K31/5386 , C07D473/18 , C07D519/00
Abstract: The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein Q, G, ring A, ring B, R1, R2, R3, R4, R5, R5a, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, R18, R19, R20, R21, R22, R23, R24, and m are defined herein. The novel purine derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. Additional embodiments relate to pharmaceutical compositions containing the compounds and to methods of using the compounds and compositions in the treatment of abnormal cell growth in mammals.
Abstract translation: 本发明涉及式(I)化合物或其药学上可接受的盐,其中Q,G,环A,环B,R1,R2,R3,R4,R5,R5a,R6,R7,R8,R9, R 11,R 12,R 13,R 14,R 15,R 16,R 17,R 18,R 19,R 20,R 21,R 22,R 23,R 24和m如本文所定义。 新型嘌呤衍生物可用于治疗哺乳动物中异常细胞生长,如癌症。 另外的实施方案涉及含有化合物的药物组合物和使用化合物和组合物治疗哺乳动物异常细胞生长的方法。
-
公开(公告)号:US12281127B2
公开(公告)日:2025-04-22
申请号:US18903345
申请日:2024-10-01
Applicant: PFIZER INC.
Inventor: Benjamin Joseph Burke , Jacob Cole Deforest , Asako Nagata , Simon Paul Planken , Jillian Elyse Spangler , Scott Channing Sutton , Hanna Maria Wisniewska , Shouliang Yang
IPC: C07D519/00 , A61K31/553 , A61P35/00
Abstract: The invention relates to compounds of Formula (I)-(III) and pharmaceutically acceptable salts thereof to their use in medicine; to compositions containing them; to processes for their preparation; and to intermediates used in such processes. The compounds the present invention may be useful in the treatment, prevention, suppression and amelioration diseases, disorders and conditions such as cancers.
-
公开(公告)号:US20150141402A1
公开(公告)日:2015-05-21
申请号:US14548749
申请日:2014-11-20
Applicant: PFIZER INC.
Inventor: Douglas Carl Behenna , Hengmiao Cheng , Sujin Cho-Schultz , Theodore Otto Johnson, JR. , John Charles Kath , Asako Nagata , Sajiv Krishnan Nair , Simon Paul Planken
IPC: C07D473/16
CPC classification number: C07D473/16 , A61K31/519 , A61K31/52 , A61K31/5377 , A61K31/5386 , C07D473/18 , C07D519/00
Abstract: The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein Q, G, ring A, ring B, R1, R2, R3, R4, R5, R5a, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, R18, R19, R20, R21, R22, R23, R24, and m are defined herein. The novel purine derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. Additional embodiments relate to pharmaceutical compositions containing the compounds and to methods of using the compounds and compositions in the treatment of abnormal cell growth in mammals.
Abstract translation: 本发明涉及式(I)化合物或其药学上可接受的盐,其中Q,G,环A,环B,R1,R2,R3,R4,R5,R5a,R6,R7,R8,R9, R 11,R 12,R 13,R 14,R 15,R 16,R 17,R 18,R 19,R 20,R 21,R 22,R 23,R 24和m如本文所定义。 新型嘌呤衍生物可用于治疗哺乳动物中异常细胞生长,如癌症。 另外的实施方案涉及含有化合物的药物组合物和使用化合物和组合物治疗哺乳动物异常细胞生长的方法。
-
-